Celldex Therapeutics SVPs Engage In Heavy Transactions
On Dec. 4, 2025, Freddy A. Jimenez, Senior Vice President General Counsel of Celldex Therapeutics (NASDAQ:CLDX), executed an open-market sale of 4,166 insider shares. See SEC Form 4 filing.
Transaction value based on SEC Form 4 reported price ($29.09); post-Transaction value based on Dec. 4, 2025 market close ($29.09).
Source Fool.com
Celldex Therapeutics Stock
€27.17
-4.160%
Currently there is a rather positive sentiment for Celldex Therapeutics with 8 Buy predictions and 3 Sell predictions.
As a result the target price of 38 € shows a positive potential of 39.86% compared to the current price of 27.17 € for Celldex Therapeutics.